SARS-CoV-2 Specific Immune Response After COVID-19 Vaccination in Cancer Patients

NCT05313074 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

311

Enrollment

OTHER_GOV

Sponsor class

Conditions

COVID-19
Cancer

Interventions

BIOLOGICAL: CoronaVac vaccine

Sponsor

National Cancer Institute, Thailand

Collaborators

[object Object]